- Home
- AMN vs MNMD Comparison
AMN vs MNMD Comparison
Compare AMN & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMN
- MNMD
- Stock Information
- Founded
- AMN 1985
- MNMD 2019
- Country
- AMN United States
- MNMD United States
- Employees
- AMN N/A
- MNMD N/A
- Industry
- AMN Assisted Living Services
- MNMD Pharmaceuticals and Biotechnology
- Sector
- AMN Health Care
- MNMD Health Care
- Exchange
- AMN Nasdaq
- MNMD Nasdaq
- Market Cap
- AMN 806.3M
- MNMD 709.9M
- IPO Year
- AMN 2001
- MNMD N/A
- Fundamental
- Price
- AMN $18.42
- MNMD $9.55
- Analyst Decision
- AMN Hold
- MNMD Strong Buy
- Analyst Count
- AMN 8
- MNMD 7
- Target Price
- AMN $23.25
- MNMD $24.71
- AVG Volume (30 Days)
- AMN 960.8K
- MNMD 1.1M
- Earning Date
- AMN 11-06-2025
- MNMD 11-06-2025
- Dividend Yield
- AMN N/A
- MNMD N/A
- EPS Growth
- AMN N/A
- MNMD N/A
- EPS
- AMN N/A
- MNMD N/A
- Revenue
- AMN $2,769,926,000.00
- MNMD N/A
- Revenue This Year
- AMN N/A
- MNMD N/A
- Revenue Next Year
- AMN N/A
- MNMD N/A
- P/E Ratio
- AMN N/A
- MNMD N/A
- Revenue Growth
- AMN N/A
- MNMD N/A
- 52 Week Low
- AMN $14.87
- MNMD $4.70
- 52 Week High
- AMN $48.49
- MNMD $11.02
- Technical
- Relative Strength Index (RSI)
- AMN 40.29
- MNMD 53.35
- Support Level
- AMN $18.16
- MNMD $8.70
- Resistance Level
- AMN $21.23
- MNMD $9.95
- Average True Range (ATR)
- AMN 0.87
- MNMD 0.55
- MACD
- AMN -0.17
- MNMD -0.02
- Stochastic Oscillator
- AMN 10.61
- MNMD 40.95
About AMN AMN Healthcare Services Inc
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are; nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. A majority of its revenue is generated from the nurse and allied solutions segment which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).